The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]
Abstract
of the prothrombin (PT), activated partial thromboplastin (PTT) and thrombin times (TT), increased levels of fibrin degradation products (FDPs), and hypofibrin~genemia.~~~~~~~~ These findings are not diagnostic of any single coagulation disorder, but reflect a complex interaction of several pathophysiologic processes depicted in Fig 1. The first and most generally recognized abnormality is the release of procoagulants from the APL cells resulting in DIC. Several types of procoagulant activity have been found in APL cells capable of activating factor X through both intrinsic and extrinsic pathways, including tissue factorlike
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Nawroth, P. P., Handley, D. A., Esmon, C. T., & Stern, D. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3460 · Cited by 582
Synthesis of fibrinolytic activator and inhibitor by endothelial cells
Loskutoff, D. J., & Edgington, T. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3903 · Cited by 479
Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia
Larson, R. A., Kondo, K., Vardiman, J. W., Butler, A. E., Golomb, H. M., & Rowley, J. D. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90994-x · Cited by 417
Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin
Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., & Gemon, M.-F. (1973) · Blood · doi:10.1182/blood.v41.4.489.489 · Cited by 338
HILLESTAD, L. K. (1957) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1957.tb00124.x · Cited by 322
Cited by
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
Zwaal, R. F. A., & Schroit, A. J. (1997) · Blood · doi:10.1182/blood.v89.4.1121 · Cited by 1,340
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Self-citationThomas, X., Anglaret, B., Thiebaut, A., Belhabri, A., Treille-Ritouet, D., Fiere, D., & Archimbaud, E. (1997) · Annals of Hematology · doi:10.1007/s002770050342 · Cited by 19
Metadata
- Authors
- Tallman, M., & Kwaan, H.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1992-02-01
- Volume
- 79
- Issue
- 3
- Pages
- 543-553
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2409883671
- Cited by
- 293
- References
- 21
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]. https://app.cochat.ai/papers/10.1182/blood.v79.3.543.543
- The paper
- Tallman, M., & Kwaan, H. (1992). Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]. Blood. https://doi.org/10.1182/blood.v79.3.543.543
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
